Methylated RNA Immunoprecipitation Sequencing uses sepecific antibodies (m6A, m5C, etc.) to modify the targeted RNAs. After the modification, Immunoprecipitation is then induced to sepecifically enrich & collect those antibody-modified RNAs. Then, use high-throughput sequencing to detect the modified RNAs.
This report contains market size and forecasts of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) in Global, including the following market information:
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Whole Transcriptome Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) include Epigentek, Illumina, Merck, Cloudseq Biotech Inc., CD Genomics, Arraystar and LC Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Segment Percentages, by Type, 2021 (%)
Whole Transcriptome Sequencing
Incomplete Transcriptome Sequencing
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Segment Percentages, by Application, 2021 (%)
Cell Differentiation Study
Developmental Biology Study
Disease Development Study
Heat Shock Response Study
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Epigentek
Illumina
Merck
Cloudseq Biotech Inc.
CD Genomics
Arraystar
LC Sciences